Australia's Proteomics International soars on distribution deal with Healius
BUZZ-Australia's Proteomics International soars on distribution deal with Healius ** Proteomics International PIQ.AX rise as much as 50% to A$0.225, their highest level since May 6
** Signs exclusive pathology distribution partner with Healius HLS.AX for its Promarker portfolio of predictive and diagnostic blood tests in Australia
** About 1.1 mln shares change hands, 1.9x the 30-day average of 579,223
** Stock down 71% YTD, including moves in the current session
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028